Shopping Cart
- Remove All
- Your shopping cart is currently empty
DRX-065 is a stabilized and deuterated R-enantiomer of pioglitazone. DRX-065 has pharmacological properties desirable for the treatment of NASH (mitochondrial function modulation, non-steroidal anti-inflammatory effects, and glucose lowering effects) without the undesired PPARγ-related weight gain side effect.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $698 | 10-14 weeks | |
5 mg | $1,470 | 10-14 weeks | |
10 mg | $1,990 | 10-14 weeks | |
25 mg | $2,950 | 10-14 weeks | |
50 mg | $3,980 | 10-14 weeks | |
100 mg | $5,378 | 10-14 weeks |
Description | DRX-065 is a stabilized and deuterated R-enantiomer of pioglitazone. DRX-065 has pharmacological properties desirable for the treatment of NASH (mitochondrial function modulation, non-steroidal anti-inflammatory effects, and glucose lowering effects) with |
Alias | DRX065, DRX 065, deuterated R-enantiomer of pioglitazone |
Molecular Weight | 357.45 |
Formula | C19H20N2O3S |
Cas No. | 1259828-75-5 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.